These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18232680)

  • 1. Statistical confidence for variable selection in QSAR models via Monte Carlo cross-validation.
    Konovalov DA; Sim N; Deconinck E; Vander Heyden Y; Coomans D
    J Chem Inf Model; 2008 Feb; 48(2):370-83. PubMed ID: 18232680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benchmarking of QSAR models for blood-brain barrier permeation.
    Konovalov DA; Coomans D; Deconinck E; Heyden YV
    J Chem Inf Model; 2007; 47(4):1648-56. PubMed ID: 17602606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robust cross-validation of linear regression QSAR models.
    Konovalov DA; Llewellyn LE; Vander Heyden Y; Coomans D
    J Chem Inf Model; 2008 Oct; 48(10):2081-94. PubMed ID: 18826208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of gastro-intestinal absorption using multivariate adaptive regression splines.
    Deconinck E; Xu QS; Put R; Coomans D; Massart DL; Vander Heyden Y
    J Pharm Biomed Anal; 2005 Oct; 39(5):1021-30. PubMed ID: 16040225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SAMFA: simplifying molecular description for 3D-QSAR.
    Manchester J; Czermiński R
    J Chem Inf Model; 2008 Jun; 48(6):1167-73. PubMed ID: 18503264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction and mechanistic interpretation of human oral drug absorption using MI-QSAR analysis.
    Iyer M; Tseng YJ; Senese CL; Liu J; Hopfinger AJ
    Mol Pharm; 2007; 4(2):218-31. PubMed ID: 17397237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QSAR modelling for mutagenic potency of heteroaromatic amines by optimal SMILES-based descriptors.
    Toropov AA; Toropova AP; Benfenati E
    Chem Biol Drug Des; 2009 Mar; 73(3):301-12. PubMed ID: 19207466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative structure-activity relationship (QSAR) modeling of human blood: air partitioning with proper statistical methods and validation.
    Basak SC; Mills D; Hawkins DM; Kraker JJ
    Chem Biodivers; 2009 Apr; 6(4):487-502. PubMed ID: 19353545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-brain barrier permeability mechanisms in view of quantitative structure-activity relationships (QSAR).
    Bujak R; Struck-Lewicka W; Kaliszan M; Kaliszan R; Markuszewski MJ
    J Pharm Biomed Anal; 2015 Apr; 108():29-37. PubMed ID: 25703237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico ADME modelling: prediction models for blood-brain barrier permeation using a systematic variable selection method.
    Narayanan R; Gunturi SB
    Bioorg Med Chem; 2005 Apr; 13(8):3017-28. PubMed ID: 15781411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new strategy of outlier detection for QSAR/QSPR.
    Cao DS; Liang YZ; Xu QS; Li HD; Chen X
    J Comput Chem; 2010 Feb; 31(3):592-602. PubMed ID: 19530115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive QSAR modeling of aldose reductase inhibitors using Monte Carlo feature selection.
    Nantasenamat C; Monnor T; Worachartcheewan A; Mandi P; Isarankura-Na-Ayudhya C; Prachayasittikul V
    Eur J Med Chem; 2014 Apr; 76():352-9. PubMed ID: 24589490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploration of linear modelling techniques and their combination with multivariate adaptive regression splines to predict gastro-intestinal absorption of drugs.
    Deconinck E; Coomans D; Vander Heyden Y
    J Pharm Biomed Anal; 2007 Jan; 43(1):119-30. PubMed ID: 16859855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
    Mandal AS; Roy K
    Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QSAR models based on isomorphic and nonisomorphic data fusion for predicting the blood brain barrier permeability.
    Cuadrado MU; Ruiz IL; Gómez-Nieto MA
    J Comput Chem; 2007 May; 28(7):1252-60. PubMed ID: 17299834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical assessment of QSAR models of environmental toxicity against Tetrahymena pyriformis: focusing on applicability domain and overfitting by variable selection.
    Tetko IV; Sushko I; Pandey AK; Zhu H; Tropsha A; Papa E; Oberg T; Todeschini R; Fourches D; Varnek A
    J Chem Inf Model; 2008 Sep; 48(9):1733-46. PubMed ID: 18729318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theoretical investigation of passive intestinal membrane permeability using Monte Carlo method to generate drug-like molecule population.
    Sugano K
    Int J Pharm; 2009 May; 373(1-2):55-61. PubMed ID: 19429288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A quantitative structure property relationship for prediction of solubilization of hazardous compounds using GA-based MLR in CTAB micellar media.
    Ghasemi JB; Abdolmaleki A; Mandoumi N
    J Hazard Mater; 2009 Jan; 161(1):74-80. PubMed ID: 18456399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biopolymer structure simulation and optimization via fragment regrowth Monte Carlo.
    Zhang J; Kou SC; Liu JS
    J Chem Phys; 2007 Jun; 126(22):225101. PubMed ID: 17581081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative structure-retention relationship studies for taxanes including epimers and isomeric metabolites in ultra fast liquid chromatography.
    Dong PP; Ge GB; Zhang YY; Ai CZ; Li GH; Zhu LL; Luan HW; Liu XB; Yang L
    J Chromatogr A; 2009 Oct; 1216(42):7055-62. PubMed ID: 19747683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.